Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate continuation vs drug holiday in long-term bisphosphonate-treated osteoporotic patients
DRKS00000721Phase 3Terminated
- Sponsor
- Evangelisches Krankenhaus Lutherhaus gGmbH Hellweg 100
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Alendronate continuation with Drug holiday (placebo) (2 arms). Primary endpoint: Fracture risk. Started Feb 2012; status: terminated.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on DRKS00000721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000721.